Modular Pathogen-Derived Binding Domains for Precise Genome Targeting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing genome editing and gene regulation techniques face challenges in achieving ease of production, target specificity, and versatility with nucleic acid binding domains.

Innovation Solution

Development of non-naturally occurring modular nucleic acid binding domains derived from animal pathogen proteins, specifically from Legionellales and Francisella bacteria, which comprise repeat units that recognize specific bases in target nucleic acids, allowing for precise genome editing, gene regulation, and imaging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional nucleic acid binding domains (zinc-finger proteins, TALE proteins) are used for genome editing, then target specificity can be achieved, but ease of production and versatility are limited

Engineering Contradiction:
Improvetarget specificityVSAvoidease of production
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The nucleic acid binding domain is segmented into multiple repeat units, where each repeat unit independently recognizes a specific base in the target nucleic acid. This modular segmentation allows for easier production through standardized assembly of repeat units while maintaining high target specificity through the cumulative recognition capability of multiple units.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The repeat unit-based nucleic acid binding domain is designed to be universal and versatile, capable of targeting different nucleic acid sequences by simply changing the combination of repeat units. This multi-functional design enables the same platform to be used for various genome editing applications across different target sites, improving both ease of production and versatility simultaneously.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If conventional nucleic acid binding domains are used, then genome editing capability is provided, but versatility for different applications (imaging, regulation) is limited

Engineering Contradiction:
ImproveversatilityVSAvoidtarget specificity
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The nucleic acid binding domain with repeat units is designed as a universal platform that can be combined with different functional domains to achieve multiple applications including genome editing, imaging, and gene regulation. The repeat unit structure itself maintains target specificity while the modular design enables versatility across different functional contexts.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

By segmenting the binding domain into independent repeat units that each recognize specific bases, the system allows for precise targeting while enabling combinatorial flexibility. This segmentation permits the same repeat unit library to be used across different applications by varying the functional domains attached, thus achieving both target specificity and versatility.

Inventive Principle:
Principle #1Segmentation

3Manufacturing precision

If highly specific nucleic acid binding is achieved with conventional domains, then genome editing precision is improved, but device complexity increases

Engineering Contradiction:
Improvegenome editing precisionVSAvoiddevice complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The binding domain is divided into standardized repeat units with consistent structural features and defined base recognition specificities. This segmentation into uniform modules simplifies the overall design and assembly process compared to conventional domains, while maintaining high genome editing precision through the cumulative recognition of multiple repeat units targeting specific nucleic acid sequences.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20250361275A1Animal Pathogen-Derived Polypeptides and Uses Thereof for Genetic Engineering
Publication Date: 2025.11.27 ALTIUS INST FOR BIOMEDICAL SCI
  • US20250361275A1 patent drawing
  • US20250361275A1 patent drawing
  • US20250361275A1 patent drawing

AI summary

Provided herein are polypeptides, compositions, and methods for use thereof for genetic and epigenomic engineering, including, genome editing and gene regulation. These polypeptides and compositions include nucleic acid binding domains that bind to a target nucleic acid of interest. The nucleic acid binding domains include repeat units derived from repeat units identified in proteins from animal pathogens such as bacterium of the order Legionellales and the species Legionella and Francisella.